Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume -, Issue -, Pages 201818357
Publisher
Proceedings of the National Academy of Sciences
Online
2019-01-19
DOI
10.1073/pnas.1818357116
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Renin–Angiotensin System Inhibitors to Mitigate Cancer Treatment–Related Adverse Events
- (2018) Matthias Pinter et al. CLINICAL CANCER RESEARCH
- Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy
- (2017) Matthias Pinter et al. Science Translational Medicine
- Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer
- (2015) Carol Aghajanian et al. GYNECOLOGIC ONCOLOGY
- The Role of Mechanical Forces in Tumor Growth and Therapy
- (2014) Rakesh K. Jain et al. Annual Review of Biomedical Engineering
- Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
- (2014) Rakesh K. Jain CANCER CELL
- Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes
- (2014) Shali Chen et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
- (2014) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Fibroblast heterogeneity in the cancer wound
- (2014) Daniel Öhlund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Histologic Parameters Predictive of Disease Outcome in Women with Advanced Stage Ovarian Carcinoma Treated with Neoadjuvant Chemotherapy
- (2014) Damanzoopinder Samrao et al. Translational Oncology
- Defining a therapeutic window for the novel TGF-β inhibitor LY2157299 monohydrate based on a pharmacokinetic/pharmacodynamic model
- (2013) Ivelina Gueorguieva et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
- (2013) Rakesh K. Jain JOURNAL OF CLINICAL ONCOLOGY
- Latest research and treatment of advanced-stage epithelial ovarian cancer
- (2013) Robert L. Coleman et al. Nature Reviews Clinical Oncology
- MicroRNAs in kidney diseases: new promising biomarkers for diagnosis and monitoring
- (2013) F. P. Schena et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis
- (2012) Christoph Roderburg et al. JOURNAL OF HEPATOLOGY
- Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
- (2012) Vikash P. Chauhan et al. Nature Nanotechnology
- Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors
- (2012) T. Stylianopoulos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TGF- blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma
- (2012) J. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TGF-β Blockade Controls Ascites by Preventing Abnormalization of Lymphatic Vessels in Orthotopic Human Ovarian Carcinoma Models
- (2011) Shan Liao et al. CLINICAL CANCER RESEARCH
- MiR-133a regulates collagen 1A1: Potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension
- (2011) Giovanna Castoldi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- TGF- /Smad3 Signaling Promotes Renal Fibrosis by Inhibiting miR-29
- (2011) W. Qin et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Suppression of microRNA-29 Expression by TGF- 1 Promotes Collagen Expression and Renal Fibrosis
- (2011) B. Wang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
- (2011) B. Diop-Frimpong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Induction of Heart Valve Lesions by Small-Molecule ALK5 Inhibitors
- (2011) Mark J. Anderton et al. TOXICOLOGIC PATHOLOGY
- miR-29 Is a Major Regulator of Genes Associated with Pulmonary Fibrosis
- (2010) Leah Cushing et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- MicroRNA-29, a key regulator of collagen expression in systemic sclerosis
- (2010) Britta Maurer et al. ARTHRITIS AND RHEUMATISM
- Connection between inflammation and carcinogenesis in gastrointestinal tract: Focus on TGF-β signaling
- (2010) Suntaek Hong WORLD JOURNAL OF GASTROENTEROLOGY
- Companies Waver in Efforts To Target Transforming Growth Factor in Cancer
- (2009) K. Garber JNCI-Journal of the National Cancer Institute
- Cancer biomarker profiling with microRNAs
- (2008) Stefanie S Jeffrey NATURE BIOTECHNOLOGY
- Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
- (2008) E. van Rooij et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search